Publication | Open Access

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

VaccinologyVaccinationVaccine SafetyPhase 1BVaccine DevelopmentVaccine SurveillanceImmunologyVaccine TestingDose-response StudyVaccine EfficacyMedicineHealthy Adults